Patients Preference With Self-Injection: The PRISM Study
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine which short-acting blood thinner
(low-molecular-weight heparin [Enoxaparin] or unfractionated heparin) is associated with less
discomfort and bruising when given as a subcutaneous (under the skin) injection before and
after a planned surgery or procedure in patients who temporarily stop warfarin.